niacin has been researched along with Recrudescence in 18 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This post hoc analysis from the Coronary Drug Project (CDP) evaluated the effects of niacin monotherapy on clinical outcomes in patients with and without the metabolic syndrome (MS)." | 9.12 | Benefits of niacin in patients with versus without the metabolic syndrome and healed myocardial infarction (from the Coronary Drug Project). ( Canner, PL; Furberg, CD; McGovern, ME, 2006) |
| " The AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial, which compared combined niacin/simvastatin with simvastatin alone, failed to demonstrate an incremental benefit of niacin among patients with atherosclerotic CVD and on-treatment low-density lipoprotein cholesterol values <70 mg/dl, but this study had some limitations." | 8.88 | Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Ou ( Baer, JT; Blaha, MJ; Blumenthal, RS; Michos, ED; Sibley, CT, 2012) |
| "Skin flushing after niacin (methylnicotinate, vitamin B(3)) stimulation is a biological marker of availability of polyunsaturated fatty acids (PUFA)." | 7.76 | Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder. ( Baur, K; Nenadic, I; Rudolph, N; Sauer, H; Smesny, S, 2010) |
| "Niacin (vitamin B3) flushing--a marker of altered prostaglandin signaling--is indirectly linked to the phospholipid-prostaglandin metabolism." | 7.73 | Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia. ( Baur, K; Berger, G; Riemann, S; Rosburg, T; Rudolph, N; Sauer, H; Smesny, S, 2005) |
| "This post hoc analysis from the Coronary Drug Project (CDP) evaluated the effects of niacin monotherapy on clinical outcomes in patients with and without the metabolic syndrome (MS)." | 5.12 | Benefits of niacin in patients with versus without the metabolic syndrome and healed myocardial infarction (from the Coronary Drug Project). ( Canner, PL; Furberg, CD; McGovern, ME, 2006) |
| " The AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial, which compared combined niacin/simvastatin with simvastatin alone, failed to demonstrate an incremental benefit of niacin among patients with atherosclerotic CVD and on-treatment low-density lipoprotein cholesterol values <70 mg/dl, but this study had some limitations." | 4.88 | Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Ou ( Baer, JT; Blaha, MJ; Blumenthal, RS; Michos, ED; Sibley, CT, 2012) |
| "Skin flushing after niacin (methylnicotinate, vitamin B(3)) stimulation is a biological marker of availability of polyunsaturated fatty acids (PUFA)." | 3.76 | Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder. ( Baur, K; Nenadic, I; Rudolph, N; Sauer, H; Smesny, S, 2010) |
| "Niacin (vitamin B3) flushing--a marker of altered prostaglandin signaling--is indirectly linked to the phospholipid-prostaglandin metabolism." | 3.73 | Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia. ( Baur, K; Berger, G; Riemann, S; Rosburg, T; Rudolph, N; Sauer, H; Smesny, S, 2005) |
| "Dalcetrapib has been well tolerated at the 600-mg dose." | 2.48 | An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels. ( Arsenault, BJ; Brodeur, MR; Rhainds, D; Tardif, JC, 2012) |
| "Although pellagra is still common in some parts of the world, it is now rare in North America." | 1.26 | Pellagra. ( DesGroseilliers, JP; Shiffman, NJ, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rivadeneira, A | 1 |
| Moyer, P | 1 |
| Salciccioli, JD | 1 |
| Huyen, MN | 1 |
| Buu, TN | 1 |
| Tiemersma, E | 1 |
| Lan, NT | 1 |
| Dung, NH | 1 |
| Kremer, K | 1 |
| Soolingen, DV | 1 |
| Cobelens, FG | 1 |
| Rahimy, E | 1 |
| Gaynon, MW | 1 |
| Paulus, YM | 1 |
| Alexander, JL | 1 |
| Mansour, SE | 1 |
| Smesny, S | 2 |
| Baur, K | 2 |
| Rudolph, N | 2 |
| Nenadic, I | 1 |
| Sauer, H | 2 |
| Michos, ED | 1 |
| Sibley, CT | 1 |
| Baer, JT | 1 |
| Blaha, MJ | 1 |
| Blumenthal, RS | 1 |
| Rhainds, D | 1 |
| Arsenault, BJ | 1 |
| Brodeur, MR | 1 |
| Tardif, JC | 1 |
| GROEBEN, D | 1 |
| NEUMARK, HJ | 1 |
| KLINGE, A | 1 |
| BLOEDORN, H | 1 |
| SUDHOF, H | 1 |
| STEINHOFF, A | 1 |
| LANGER, C | 1 |
| Rosburg, T | 1 |
| Riemann, S | 1 |
| Berger, G | 1 |
| Canner, PL | 1 |
| Furberg, CD | 1 |
| McGovern, ME | 1 |
| Il'in, VN | 1 |
| Stepanov, NV | 1 |
| Ikhaev, ZA | 1 |
| Sharonin, GV | 1 |
| Bogdanets, LI | 1 |
| Hannan, F | 1 |
| Davoren, P | 1 |
| Earthman, TP | 1 |
| Odom, L | 1 |
| Mullins, CA | 1 |
| Blankenhorn, DH | 1 |
| Alaupovic, P | 1 |
| Wickham, E | 1 |
| Chin, HP | 1 |
| Azen, SP | 1 |
| Lucey, MR | 1 |
| DesGroseilliers, JP | 1 |
| Shiffman, NJ | 1 |
2 reviews available for niacin and Recrudescence
| Article | Year |
|---|---|
Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Ou
Topics: Aged; Cardiovascular Diseases; Coronary Artery Disease; Drug Therapy, Combination; Female; Follow-Up | 2012 |
An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels.
Topics: Amides; Animals; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol Ester Transfer Prote | 2012 |
2 trials available for niacin and Recrudescence
| Article | Year |
|---|---|
Benefits of niacin in patients with versus without the metabolic syndrome and healed myocardial infarction (from the Coronary Drug Project).
Topics: Cholesterol, HDL; Follow-Up Studies; Humans; Hypolipidemic Agents; Metabolic Syndrome; Myocardial In | 2006 |
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.
Topics: Apolipoprotein C-III; Apolipoproteins; Apolipoproteins C; Colestipol; Coronary Angiography; Coronary | 1990 |
14 other studies available for niacin and Recrudescence
| Article | Year |
|---|---|
Pellagra in the USA: unusual manifestations of a rare entity.
Topics: Diarrhea; Female; Humans; Middle Aged; Niacin; Pellagra; Recurrence; Thiamine; Tongue; Treatment Out | 2019 |
Tuberculosis relapse in Vietnam is significantly associated with Mycobacterium tuberculosis Beijing genotype infections.
Topics: Adult; Aged; Antitubercular Agents; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Fo | 2013 |
Potentially Reversible Effect of Niacin Therapy on Edema From Retinal Vein Occlusion.
Topics: Administration, Oral; Humans; Hyperlipidemias; Hypertension; Macular Edema; Male; Middle Aged; Niaci | 2016 |
Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder.
Topics: Adult; Biomarkers; Depressive Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manua | 2010 |
[Experience report on INH with special reference to the resistance and frequency of the relapse].
Topics: Niacin; Nicotinic Acids; Recurrence; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
[Relapses after isoniazid treatment].
Topics: Aminosalicylic Acid; Collapse Therapy; Isoniazid; Niacin; Nicotinic Acids; Recurrence; Thiosemicarba | 1954 |
[Recurrences of tuberculous meningitis in adults; frequency and prognosis in connection with therapy].
Topics: Aminosalicylic Acid; Niacin; Nicotinic Acids; Prognosis; Recurrence; Streptomycin; Tuberculosis; Tub | 1955 |
[Clinical recurrence of tuberculosis after tebafen treatment].
Topics: Niacin; Nicotinic Acids; Recurrence; Thiosemicarbazones; Tuberculosis | 1956 |
Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia.
Topics: Acute Disease; Adult; Case-Control Studies; Female; Flushing; Humans; Male; Niacin; Nicotinic Acids; | 2005 |
[Postoperative antithrombotic therapy in acute occlusion of the major arteries of the extremities].
Topics: Acute Disease; Adolescent; Adult; Aged; Arm; Arterial Occlusive Diseases; Aspirin; Dextrans; Female; | 1980 |
Use of nicotinic acid in the management of recurrent hypoglycemic episodes in diabetes.
Topics: Blood Glucose; Chronic Disease; Diabetes Mellitus, Type 1; Female; Humans; Hypoglycemia; Insulin; Mi | 2001 |
Lactic acidosis associated with high-dose niacin therapy.
Topics: Acidosis, Lactic; Adult; Delayed-Action Preparations; Humans; Hyperlipidemias; Lactates; Male; Niaci | 1991 |
Recurrent pellagra in Crohn's disease.
Topics: Acute Disease; Adolescent; Adult; Crohn Disease; Follow-Up Studies; Humans; Male; Pellagra; Recurren | 1982 |
Pellagra.
Topics: Adult; Canada; Diagnosis, Differential; Female; Humans; Pellagra; Recurrence; Vitamins | 1976 |